UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Overall survival results of ceritinib in ALKi-naïve patients with ALK-rearranged NSCLC (ASCEND-3)

Annals of oncology, 2018-10, Vol.29, p.viii745-viii745

2018

Volltextzugriff (PDF)

LBA57Overall survival results of ceritinib in ALKi-naïve patients with ALK-rearranged NSCLC (ASCEND-3)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial

The lancet respiratory medicine, 2019-05, Vol.7 (5), p.387-401

2019

Volltextzugriff (PDF)

Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin

Genome research, 2019-03, Vol.29 (3), p.418-427

2019

Volltextzugriff (PDF)

MET Amplification and Exon 14 Splice Site Mutation Define Unique Molecular Subgroups of Non-Small Cell Lung Carcinoma with Poor Prognosis

Clinical cancer research, 2016-06, Vol.22 (12), p.3048-3056

2016

Volltextzugriff (PDF)

Population-based differences in treatment outcome following anticancer drug therapies

The lancet oncology, 2010, Vol.11 (1), p.75-84

2010

Volltextzugriff (PDF)

Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers

Scientific reports, 2016-05, Vol.6 (1), p.26591-26591, Article 26591

2016

Volltextzugriff (PDF)

Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the phase III IMpower150 trial

Journal for immunotherapy of cancer, 2022-02, Vol.10 (2), p.e003027

2022

Volltextzugriff (PDF)

Canakinumab with and without pembrolizumab in patients with resectable non-small-cell lung cancer: CANOPY-N study design

Future oncology (London, England), 2021-04, Vol.17 (12), p.1459-1472

2021

Volltextzugriff (PDF)

A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma

Investigational new drugs, 2021-10, Vol.39 (5), p.1375-1382

2021

Volltextzugriff (PDF)

Overcoming immunosuppression and pro-tumor inflammation in lung cancer with combined IL-1β and PD-1 inhibition

Future oncology (London, England), 2022-09, Vol.18 (27), p.3085-3100

2022

Volltextzugriff (PDF)

Detection of ALK Rearrangement by Immunohistochemistry in Lung Adenocarcinoma and the Identification of a Novel EML4-ALK Variant

Journal of thoracic oncology, 2013-07, Vol.8 (7), p.883-891

2013

Volltextzugriff (PDF)

Twenty‐five years of Respirology: Advances in lung cancer

Respirology (Carlton, Vic.), 2020-01, Vol.25 (1), p.26-31

2020

Volltextzugriff (PDF)

A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma

Cancer, 2017-10, Vol.123 (20), p.3977-3985

2017

Volltextzugriff (PDF)

Converting MMSE to MoCA and MoCA 5‐minute protocol in an educationally heterogeneous sample with stroke or transient ischemic attack

International journal of geriatric psychiatry, 2018-05, Vol.33 (5), p.729-734

2018

Volltextzugriff (PDF)

Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis

The Journal of pathology, 2015-09, Vol.237 (1), p.38-49

2015

Volltextzugriff (PDF)

Crizotinib in the management of advanced-stage non-small-cell lung cancer

Future oncology (London, England), 2015-03, Vol.11 (5), p.735-745

2015

Volltextzugriff (PDF)

Estrogen receptor alpha promotes smoking-carcinogen-induced lung carcinogenesis via cytochrome P450 1B1

Journal of molecular medicine (Berlin, Germany), 2015-11, Vol.93 (11), p.1221-1233

2015

Volltextzugriff (PDF)

Genotype-Specific Genomic Markers Associated with Primary Hepatomas, Based on Complete Genomic Sequencing of Hepatitis B Virus

Journal of Virology, 2008-04, Vol.82 (7), p.3604-3611

2008

Volltextzugriff (PDF)

Can the concept of Health Promoting Schools help to improve students' health knowledge and practices to combat the challenge of communicable diseases: Case study in Hong Kong?

BMC public health, 2008-01, Vol.8 (1), p.42-42, Article 42

2008

Volltextzugriff (PDF)

STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells

The FASEB journal, 2005-08, Vol.19 (10), p.1296-1298

2005

Volltextzugriff (PDF)

Anticancer efficacy of 5F in NNK-induced lung cancer development of A/J mice and human lung cancer cells

Journal of molecular medicine (Berlin, Germany), 2010-12, Vol.88 (12), p.1265-1276

2010

Volltextzugriff (PDF)

Clinical Outcomes with Erlotinib in Patients with Epidermal Growth Factor Receptor Mutation

Drugs (New York, N.Y.), 2012-01, Vol.72 (Suppl 1), p.3-10

2012

Volltextzugriff (PDF)

Combining chemotherapy with epidermal growth factor receptor inhibition in advanced non-small cell lung cancer

Therapeutic Advances in Medical Oncology, 2012-07, Vol.4 (4), p.173-181

2012

Volltextzugriff (PDF)

1 – 25 von 147

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(127)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(125)
Life Sciences & Biomedicine
(77)
Humans
(62)
Female
(41)
Male
(38)
Technology
(36)
Middle Aged
(30)
Adult
(27)
Engineering
(24)
Physical Sciences
(23)
Oncology
(22)
Biological And Medical Sciences
(20)
Engineering, Electrical & Electronic
(20)
Aged
(19)
Medical Sciences
(17)
Lung Cancer
(15)
Animals
(13)
Chemistry
(12)
Lung Neoplasms - Drug Therapy
(11)
Materials Science
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Overall survival results of ceritinib in ALKi-naïve patients with ALK-rearranged NSCLC (ASCEND-3)

LBA57Overall survival results of ceritinib in ALKi-naïve patients with ALK-rearranged NSCLC (ASCEND-3)

Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial

Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin

MET Amplification and Exon 14 Splice Site Mutation Define Unique Molecular Subgroups of Non-Small Cell Lung Carcinoma with Poor Prognosis

Population-based differences in treatment outcome following anticancer drug therapies

Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers

Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the phase III IMpower150 trial

Canakinumab with and without pembrolizumab in patients with resectable non-small-cell lung cancer: CANOPY-N study design

A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma

Overcoming immunosuppression and pro-tumor inflammation in lung cancer with combined IL-1β and PD-1 inhibition

Detection of ALK Rearrangement by Immunohistochemistry in Lung Adenocarcinoma and the Identification of a Novel EML4-ALK Variant

Twenty‐five years of Respirology: Advances in lung cancer

A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma

Converting MMSE to MoCA and MoCA 5‐minute protocol in an educationally heterogeneous sample with stroke or transient ischemic attack

Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis

Crizotinib in the management of advanced-stage non-small-cell lung cancer

Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium

Estrogen receptor alpha promotes smoking-carcinogen-induced lung carcinogenesis via cytochrome P450 1B1

Genotype-Specific Genomic Markers Associated with Primary Hepatomas, Based on Complete Genomic Sequencing of Hepatitis B Virus

Can the concept of Health Promoting Schools help to improve students' health knowledge and practices to combat the challenge of communicable diseases: Case study in Hong Kong?

STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells

Anticancer efficacy of 5F in NNK-induced lung cancer development of A/J mice and human lung cancer cells

Clinical Outcomes with Erlotinib in Patients with Epidermal Growth Factor Receptor Mutation

Combining chemotherapy with epidermal growth factor receptor inhibition in advanced non-small cell lung cancer

Suchergebnisse filtern